<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04149873</url>
  </required_header>
  <id_info>
    <org_study_id>CMFHR 10460(IRB10407-008)</org_study_id>
    <nct_id>NCT04149873</nct_id>
  </id_info>
  <brief_title>Effectness of Treatment With Mechanical Insufflation-Exsufflation</brief_title>
  <official_title>Effectness of Treatment With Mechanical Insufflation-Exsufflation in Surgical Critically Ill Patients With Impaired Cough Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chimei Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chimei Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients defined with impaired cough function as maximum expiratory pressure (MEP) &lt; 60cmH2O.&#xD;
      Collected the patients in our surgical ICU who are able to reach 6-8CC/IBW under pressure&#xD;
      support mode for 24 hours and MEP &lt; 60cmH2O. Then the patients will be allocated to 3 groups&#xD;
      to receive (1) conventional CPT (control group) (2) MI-E (study group A) (3) MI-E plus CPT&#xD;
      (study group B) until 48 hours after extubation. Reintubation rates, ICU mortality and&#xD;
      post-extubation ICU length of stay will be analyzed to evaluate its effects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endotracheal intubation and mechanical ventilation are always used to treat acute respiratory&#xD;
      failure in critically ill patients. Successful weaning from ventilator and extubation are&#xD;
      crucial to determine the prognosis when patient's underlying disease getting improvement. The&#xD;
      reasons for extubation failure include lack of improvement of on the work of breathing,&#xD;
      hypoxemia, respiratory acidosis, conscious disturbance and retained respiratory secretions,&#xD;
      etc. In our clinical practice, the factor of retained respiratory secretions plays an&#xD;
      important role in successful extubation.&#xD;
&#xD;
      Traditional chest physiotherapy (CPT) is commonly used to help the critically patients in the&#xD;
      effective expulsion of airway secretions. In recent years, new advanced techniques mechanical&#xD;
      insufflations-exsufflation (MI-E) and high frequency chest wall oscillation (HFCWO)have been&#xD;
      developed to get more effective to remove secretions for patients suffered from acute&#xD;
      respiratory failure. The above devices have been described as an effective techniques for&#xD;
      patients with chronic neuromuscular weakness, cystic fibrosis and bronchiectasis. By the&#xD;
      knowledge, only one study mentioned about MI-E could reduce the reintubation rate and shorten&#xD;
      the ICU length of stay. But its limitations include less of case number and not focusing on&#xD;
      impaired cough function patients.&#xD;
&#xD;
      In this study, patients defined with impaired cough function as maximum expiratory pressure&#xD;
      (MEP) &lt; 60cmH2O. Collected the patients in our surgical ICU who are able to reach 6-8CC/IBW&#xD;
      under pressure support mode for 24 hours and MEP &lt; 60cmH2O. Then the patients will be&#xD;
      allocated to 3 groups to receive (1) conventional CPT (control group) (2) MI-E (study group&#xD;
      A) (3) MI-E plus CPT (study group B) until 48 hours after extubation. Reintubation rates, ICU&#xD;
      mortality and post-extubation ICU length of stay will be analyzed to evaluate its effects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mortality rate</measure>
    <time_frame>1 year</time_frame>
    <description>One year mortality rate</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Mortality</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group' has the treatment with [Physical chest care ]</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental group-A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>'Experimental group-A' has the treatment with [Mechanical-Insufflation- Exsufflation]</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental group-B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>'Experimental group-B' has the treatment with [Mechanical-Insufflation- Exsufflation] and [Physical chest care]</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MIE</intervention_name>
    <description>MIE</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Experimental group-A</arm_group_label>
    <arm_group_label>Experimental group-B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria.&#xD;
&#xD;
          -  1.Written Informed Consent given by the patient or, if not possible, by a legally&#xD;
             authorized representative and/or an independent physician as authorized by the&#xD;
             competent ethics committee (EC) or independent review board (IRB) and local&#xD;
             regulations.&#xD;
&#xD;
          -  2.To be at least 20 years of age.&#xD;
&#xD;
          -  3.To be treated in an ICU at the time of enrollment.&#xD;
&#xD;
          -  4.Endotracheal tube in place&#xD;
&#xD;
          -  5.The patient is mechanically ventilated and reach:&#xD;
&#xD;
               1. Ventialtopr: Pressure support mode&#xD;
&#xD;
               2. reach 6-8CC/IBW, ideal body weight for 24 hours&#xD;
&#xD;
               3. MEP, maximum expiratory pressure &lt; 60cmH2O&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  1.The patient or legally authorized representative refuse&#xD;
&#xD;
          -  2.&lt; 20 years of age.&#xD;
&#xD;
          -  3.Neither endotracheal tube nor mechanical ventilator use&#xD;
&#xD;
          -  4.The patient is mechanically ventilated, but:&#xD;
&#xD;
               1. The ventialtopr mode NOT: Pressure support mode&#xD;
&#xD;
               2. No reach 6-8CC/IBW, ideal body weight for 24 hours&#xD;
&#xD;
               3. MEP, maximum expiratory pressure &gt; 60cmH2O&#xD;
&#xD;
          -  5.Participation as subject in another interventional study within 30 days prior to the&#xD;
             first dose of study treatment, or planned participation in such a study during the&#xD;
             study or within 30 days of its completion by the patient.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kuo-Chen Cheng, Chief</last_name>
    <role>Study Chair</role>
    <affiliation>Chi Mei Medical Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Intensive Care Medicine; Chi Mei Medical Center</name>
      <address>
        <city>Tainan</city>
        <zip>710</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>January 24, 2018</study_first_submitted>
  <study_first_submitted_qc>October 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2019</study_first_posted>
  <last_update_submitted>October 31, 2019</last_update_submitted>
  <last_update_submitted_qc>October 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chimei Medical Center</investigator_affiliation>
    <investigator_full_name>Kuo-Chen Cheng</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

